These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12814463)

  • 41. Impact and modulation of nasal obstruction.
    Horak F
    Allergy; 2002; 57 Suppl 75():25-8. PubMed ID: 12492726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
    Pradalier A; Neukirch C; Dreyfus I; Devillier P
    Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Desloratadine-montelukast combination improves quality of life and decreases nasal obstruction in patients with perennial allergic rhinitis.
    Cingi C; Oghan F; Eskiizmir G; Yaz A; Ural A; Erdogmus N
    Int Forum Allergy Rhinol; 2013 Oct; 3(10):801-6. PubMed ID: 23733270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effect of desloratadine on quality of life of patients with seasonal allergic rhinitis].
    Li Y; Liu F
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(10):439-42. PubMed ID: 18720881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
    Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
    Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion.
    McLeod RL; Mingo GG; Xu X; Palamanda J; Hunter JC; Jia Y
    Am J Rhinol Allergy; 2009; 23(6):e17-22. PubMed ID: 19769798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
    Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
    Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis].
    Lu Y; Yin M; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Aug; 49(8):659-67. PubMed ID: 25351124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit.
    Day JH; Briscoe MP; Ratz JD; Ellis AK; Yao R; Danzig M
    Allergy Asthma Proc; 2009; 30(3):270-6. PubMed ID: 19549428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
    Bachert C; van Cauwenberge P
    Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis.
    Meltzer EO; Philip G; Weinstein SF; LaForce CF; Malice MP; Dass SB; Santanello NC; Reiss TF
    Am J Rhinol; 2005; 19(6):591-8. PubMed ID: 16402647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Onset of action of loratadine/montelukast in seasonal allergic rhinitis patients exposed to grass pollen.
    Horak F; Zieglmayer P; Zieglmayer R; Lemell P
    Arzneimittelforschung; 2010; 60(5):249-55. PubMed ID: 20533761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials.
    Canonica GW; Tarantini F; Compalati E; Penagos M
    Allergy; 2007 Apr; 62(4):359-66. PubMed ID: 17362245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
    Ciprandi G; Tosca MA; Milanese M; Schenone G; Ricca V
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis.
    Wilson AM; Orr LC; Sims EJ; Lipworth BJ
    Clin Exp Allergy; 2001 Jan; 31(1):61-8. PubMed ID: 11167952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients.
    Patel P; Patel D
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):287-94. PubMed ID: 18814452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
    Prenner B; Anolik R; Danzig M; Yao R
    Allergy Asthma Proc; 2009; 30(3):263-9. PubMed ID: 19549427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
    Mucha SM; deTineo M; Naclerio RM; Baroody FM
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis].
    Jia MH; Chen XY; Zhang Y; Liao ZS
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):369-373. PubMed ID: 29871264
    [No Abstract]   [Full Text] [Related]  

  • 60. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
    Nayak A; Langdon RB
    Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.